Literature DB >> 243112

Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.

B Olsson, K Dornbusch, C E Nord.   

Abstract

Using the agar dilution technique, 231 strains of Bacteroides fragilis, isolated during a 2-year period from human infections, were identified at subspecies level and were tested for susceptibility to 13 beta-lactam antibiotics. The penicillins were benzylpenicillin, ampicillin, carbenicillin, cloxacillin, and the recently described penicillin derivatives cyclacillin, ticarcillin, and PC-904. The following cephalosporin derivatives were tested: cephaloridine, cephalothin, cephalexin, cefamandole and cefuroxime. The cephamycin C derivative cefoxitin was also included in the study. Cefoxitin was the most effective drug tested since more than 80% of the strains were inhibited by 8 microgram/ml or less, and no strain had a minimal inhibitory concentration (MIC) of more than 64 microgram/ml. There was no marked difference in sensitivity among the subspecies with exception of subspecies vulgatus, which was slightly more sensitive to all antibiotics tested. The size of the inoculum was an important factor for obtaining reproducible results in the sensitivity tests. Increased inocula resulted in markedly higher MICs for cephaloridine and cefuroxime. Production of beta-lactamase was performed on all isolates by a chromogenic cephalosporin substrate and about 90% of the strains were found to be beta-lactamase producers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 243112     DOI: 10.1007/bf02126677

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  36 in total

1.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

3.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

4.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy.

Authors:  M Matthew; A M Harris
Journal:  J Gen Microbiol       Date:  1976-05

Review 5.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

6.  Cefuroxime, a new cephalosporin antibiotic: activity in vitro.

Authors:  C H O'Callaghan; R B Sykes; A Griffiths; J E Thornton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

Review 7.  Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal.

Authors:  G H Warren
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

8.  Management of anaerobic infections.

Authors:  S M Finegold; J G Bartlett; A W Chow; D J Flora; S L Gorbach; E J Harder; F P Tally
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

9.  Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

10.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

View more
  16 in total

1.  Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

Authors:  P C Appelbaum; A Philippon; M R Jacobs; S K Spangler; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Outer membrane permeation of Bacteroides fragilis by cephalosporins.

Authors:  A Yotsuji; J Mitsuyama; R Hori; T Yasuda; I Saikawa; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

3.  Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.

Authors:  Usha Stiefel; Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.

Authors:  M A Crosby; D W Gump
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Studies on beta-lactamase in Bacteroides fragilis.

Authors:  C E Nord; K Dornbusch; B Olsson
Journal:  Infection       Date:  1980       Impact factor: 3.553

6.  Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

7.  Variation in susceptibility patterns of species within the Bacteroides fragilis group.

Authors:  S L Hansen
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

8.  Isoelectric focusing of Bacteroides melaninogenicus group beta-lactamases.

Authors:  R M Timewell; I Phillips; J Söderholm; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

9.  Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis.

Authors:  J C Pechère; R Guay; J Dubois; R Letarte
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

10.  Encapsulated strains of Bacteroides fragilis in clinical specimens.

Authors:  A A Lindberg; P Berthold; C E Nord; A Weintraub
Journal:  Med Microbiol Immunol       Date:  1979-03-13       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.